Personalised mRNA Vaccine Shows Durable Immune Responses in Triple-Negative Breast Cancer
25 February 2026
A new study has found encouraging results from a small trial of an individualized neoantigen mRNA vaccine in patients with triple-negative breast cancer (TNBC)… Read More…









